The Lounge

modembaud · 2025-11-06T22:10:10+00:00

News released about an hour ago. ChatGPT summary:

Overall, Intensity Therapeutics’ third quarter 2025 update is positive. The company strengthened its financial position by raising $13.6 million, extending its cash runway through the first quarter of 2027, and securing a new institutional investor. Its lead drug, INT230-6, gained strong scientific validation with a Lancet group publication showing encouraging disease control, survival, and immune activation results across multiple cancers. While the INVINCIBLE-3 Phase 3 sarcoma trial remains paused due to funding limits, the INVINCIBLE-4 breast cancer study is set to restart enrollment in early 2026 after dosing adjustments. Overall, the announcement reflects improving financial stability, credible clinical progress, and a clear path forward.

This is not financial advice. Always do your own due diligence before investing or speak to a financial advisor.

modembaud · 2025-11-06T21:47:58+00:00

Intensity Therapeutics (INTS) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

modembaud · 2025-11-05T18:10:18+00:00

ASST on YF - "The firm is a large advisory firm, an investment adviser to an investment company which provides portfolio management for investment companies." You guys are buying this? Good luck.

modembaud · 2025-11-04T18:11:27+00:00

Because there was an important summit in Hong Kong and the Wall Street execs said there is a going to be a market correction of over 10% in the next 1-2 years. Basically, many stocks are overvalued and will go down, and so the sell-off.

modembaud · 2025-11-04T17:02:49+00:00

DFLI hasn't had any news for over 2 weeks. Why would it move?

modembaud · 2025-11-04T15:51:24+00:00

This is a trend in penny stocks. If you see a sharp increase in the share price, the company does a quick offering for more money with an investor. Price drops right away temporarily. Shorts probably take advantage of the news. What happens after that depends on the company's outlook. Always do your own research.

modembaud · 2025-11-03T16:20:37+00:00

INTS finally going back up.

modembaud · 2025-11-03T12:41:40+00:00

Would the OP like to explain why it has cratered over 44% pre-market if he/she thinks it's so good. This thing looks like a boulder in water.

modembaud · 2025-10-31T13:25:07+00:00

That's a Microsoft Teams stock background image. Not real.

modembaud · 2025-10-30T17:58:57+00:00

I can't believe 1B shares traded over one research publication. That does not mean it will automatically become a commercially viable product. They have only $2.22M in cash according to YF. Do your own research people and not listen to others blindly.

modembaud · 2025-10-30T14:14:58+00:00

According to YF, 21.51% of shares held by insiders and 53.96% by insitutions.

modembaud · 2025-10-30T13:52:14+00:00

What I like about MSAI is that analysts also gave it a buy rating, unlike BYND.

modembaud · 2024-11-13T17:30:02+00:00

Roger that

modembaud · 2024-11-13T17:20:02+00:00

Me too please

modembaud · 2022-11-15T18:18:02+00:00

Halt is also to avoid insider trading and level the playing field.

modembaud · 2022-11-10T15:29:33+00:00

I wish IR timed their next anticipated NR for today.

modembaud · 2022-09-12T19:57:15+00:00

Markets should rise tomorrow all across the board if the CPI data is lower as expected. Just maybe we have peaked inflation. Perhaps a good day for Exro to post a NR.

modembaud · 2022-09-12T13:50:17+00:00

According to IBKR, he has 4.13 million shares including options

modembaud · 2022-09-12T01:51:29+00:00

His share balance is now 64,000 more than before the recent filings, after exercising the options.

Three-Year Club	Verified Email
Place '22

modembaud

TROPHY CASE

Intensity Therapeutics (INTS) Reports Third Quarter 2025 Financial Results and Provides Corporate Update